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Abstract: During the evaluation of skin disease treatments, dermatologists have to clinically
measure the evolution of the pathology severity of each patient during treatment periods. Such a
process is sensitive to intra- and inter- dermatologist diagnosis. To make this severity measurement
more objective we quantify the pathology severity using a new image processing based method. We
focus on a hyperpigmentation disorder called melasma. During a treatment period, multispectral
images are taken on patients receiving the same treatment. After co-registration and segmentation
steps, we propose an algorithm to measure the intensity, the size and the homogeneity evolution
of the pathological areas. Obtained results are compared with a dermatologist diagnosis using
statistical tests on two clinical studies containing respectively 384 images from 16 patients and 352
images from 22 patients.
This research report is an update of the report 8136 [49]. It describes methods and experiments
in more details and provides more references.
Key-words: skin, hyperpigmentation, change detection, statistical inference, multispectral
∗ Morphème/Ayin
† Morphème
‡ Galderma R&D
§ Ayin
Quantiﬁcation de l'évolution de lésions cutanées par
imagerie multispectrale
Résumé : Lors de l'évaluation des traitements des maladies de peau, les dermatologues
doivent mesurer la sévérité de la pathologie de chaque patient tout au long d'une période de
traitement. Un tel procédé est sensible aux variations intra- et inter- dermatologues. Pour rendre
cette mesure de sévérité plus robuste, nous proposons d'utiliser l'imagerie spectrale. Nous nous
concentrons sur une pathologie d'hyperpigmentation cutanée appelée mélasma. Au cours d'une
période de traitement, des images multispectrales sont acquises sur une population de patients
sous traitement. Après des étapes de recalage des séries temporelles d'images et de classication
des régions d'intérêt, nous proposons une méthodologie permettant de mesurer, dans le temps, la
variation de contraste, de surface et d'homogénéité de la zone pathologique pour chaque patient.
Les résultats obtenus sont comparés à un diagnostique clinique à l'aide de tests statistiques
réalisés sur une étude clinique complète.
Ce rapport de recherche est un complément du rapport de recherche 8136 [49], aﬁn de com-
pléter la bibliographie, et de décrire plus en détail les méthodes et résultats.
Mots-clés : peau, hyperpigmentation, d'étection de changements, inférence statistique, multi-
spectral
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1 Introduction
In dermatology, speciﬁc protocols are established to quantify the evolution of lesion severity along
a treatment period. In this report, we focus on a hyperpigmentation disorder called melasma.
This disease produces darker and irregular spots on the face. Melasma has the speciﬁcity to be
symmetric w.r.t the two cheeks. Thereby, the protocol consists in applying a studied treatment
on one cheek, and a comparator treatment on the second cheek ([40]). The comparator is of-
ten chosen as the medium used for the studied treatment without active product. To render a
clinical study reliable, patients are randomized ([40]). The eﬃcacy of a treatment is then clin-
ically measured by dermatologists. To this end, a clinical score is evaluated by one or several
dermatologists on each cheek of each patient during several visits along the treatment. Finally,
a statistical test such as the Student test or the Wilcoxon test ([36]) is performed on these mea-
surements to obtain an evaluation of the studied treatment eﬃcacy relatively to the comparator
treatment ([41]). The most widely used score for melasma severity evaluation is the Melasma
Area and Severity Index (MASI) ([34, 21, 3]). It has been introduced in ([26]). The MASI splits
the face into 4 regions: forehead, left cheek, right cheek, and chin. For each region, three scores
are evaluated:
 Area (A): Measure of the area aﬀected by the disease. It is estimated on a scale ranging
from 0 to 6 as: 0 = 0%; 1 ≤ 10%; 2 = 10−29%; 3 = 30−49%; 4 = 50−69%; 5 = 70−89%
and 6 = 90− 100%.
 Darkness (D): Color of the pathological area compared with normal skin. It is graded
on a scale from 0 to 4 as follows: 0=normal skin color without evidence of hyperpig-
mentation; 1=barely visible hyperpigmentation; 2=mild hyperpigmentation; 3=moderate
hyperpigmentation; 4=severe hyperpigmentation.
 Homogeneity (H): Homogeneity of the hyperpigmentation, graded on a scale from 0 to 4 as
follows: 0=normal skin color without evidence of hyperpigmentation; 1=specks of involve-
ment; 2=small patchy areas of involvement < 1.5 cm diameter; 3=patches of involvement
> 2 cm diameter; 4=uniform skin involvement without any clear area).
To integrate these three criteria measured on the four regions: forehead (F), left cheek (LC),
right cheek (RC) and chin (C), the following equation is proposed in [26]:
MASI = 0.3(DF +HF )AF + 0.3(DLC +HLC)ALC
+ 0.3(DRC +HRC)ARC + 0.1(DC +HC)AC , (1)
where DF , DLC , DRC , DC are darknesses measured respectively on the forehead, left cheek,
right cheek and chin, HF , HLC , HRC , HC homogeneities measured respectively on the forehead,
left cheek, right cheek and chin and AF , ALC , ARC , AC areas measured respectively on the
forehead, left cheek, right cheek and chin. This MASI deﬁnition has been discussed in [41]. The
authors claim that the H criterion has signiﬁcant variations from one dermatologist to another.
They then propose to remove the H criterion from Equation (1):
MASI = 0.3DFAF + 0.3DLCALC + 0.3DRCARC + 0.1DCAC . (2)
In this report, we propose a new computer based score called diﬀerential score that measures the
variation of the pathology between two visits. The idea is to consider multispectral images from
which we automatically compute a severity score containing area (A), darkness (D) criteria as
deﬁned by the MASI. As the homogeneity (H) criterion is expert dependent, we introduce a new
Inria
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(a) baseline (b) after 1 month
(c) after 2 months (d) after 3 months
Figure 1: Time series of color images for a patient whose pathology was diagnosed as decreasing.
The diagnosis of the dermatologist using a scale from 0 to 3 was 2 (moderate) at baseline and 0
(cleared) after 3 months.
criterion H which measures the local variations of the pathology. Such a computer based score
avoids the variability on the measures obtained by human inspection. The choice of multispectral
imaging is motivated by the fact that we need more information than color imaging to evaluate
the Melasma evolution. As an example, Figure 1 shows a time series of co-registered color images.
The diagnosis of the dermatologist is a decreasing of the Melasma over time. Looking at color
images of Figure 1 doesn't allow to easily visualize such a decreasing.
The report is organized as follows: section 2 introduces the proposed methodology and the
chosen algorithms to extract the disease information from multispectral images and deﬁne the
diﬀerential score. In section 3, we present the experimental settings: we describe the two clinical
studies that we work with and expose the protocol used to evaluate the proposed diﬀerential
score. In section 4 we expose the obtained results using the two clinical studies. Finally, section
5 discusses the proposed score and concludes this report.
2 Method
In this section, we introduce the methodology to score the disease evolution with a time series
of multispectral images. After exposing the global scheme and the state of the art, we describe
the selected algorithms for extracting the information needed to compute the diﬀerential score
from images.
2.1 Proposed approach and state of the art
The quantiﬁcation of a treatment eﬃcacy along a clinical study using imaging is the comparison
of the disease severity along a sequence of images for each patient. To quantify this severity, we
ﬁrst need to extract the pathological areas in the images, and then extract features describing
the disease. Furthermore, we aim at measuring changes of the features from time t0 to time tk.
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Figure 2 summarizes the proposed approach. In this scheme, a multispectral (MS) image has
been taken for each patient at diﬀerent periods (MS images t0, MS images tk, MS images
tn). We ﬁrst segment each image taken at baseline (t0) in order to extract the pathological area
that is the region of interest (ROI) where the disease severity evolution along the clinical study is
measured. To be able to get the same ROI for each patient at diﬀerent times, we co-register the
sequence of images of each patient individually. This co-registration is done using the algorithm
described in [37] initialized by an aﬃne registration.
To evaluate the severity, we ﬁrst extract a spectral feature that provides a local severity in-
dicator on each pixel of the image. we then calculate the severity evolution using some change
detection approaches. A binary change detection is used to measure a global evolution of the
disease, and a multi-level change detection is used to evaluate the local temporal evolution.
Figure 2: Proposed scheme to evaluate a treatment eﬃcacy on a clinical study
Several methods have been described to perform the 3 steps (segmentation, feature extraction
and change detection) above mentioned:
Segmentation Numerous methods have been proposed to classify or segment multispectral
and hyperspectral images. Since the spectral space is large, a dimension reduction is usually
performed to avoid the Hughes phenomenon ([20]). Classiﬁcation or segmentation methods can
then be partitioned into three groups.
The ﬁrst group is only based on spectral features (for instance kmeans [[24]), fuzzy-C-
means ([6]), mixture analysis ([10]), mean shift ([12]), k-nearest neighbors ([13]), maximum
likelihood ([35]) or SVM ([62]) ]. The second group consists of the methods that extend the gray
scales image algorithms to spectral images [ Markov random ﬁelds ([19, 51]), extension of split
and merge algorithms ([25, 65, 59, 60]), and extension of morphological mathematics ([43, 5])].
Finally we can ﬁnd some combination of the two previous groups [([5, 61, 58])].
In this report, we propose to extract the relevant information using a projection pursuit
algorithm, to remove the shading artifacts using a compensation and then to perform the seg-
mentation using a SVM that embeds non linear separable classes ([48]).
Feature extraction Several approaches have been proposed to analyse the spectrum of the
skin from multipsectral images. The most popular spectral analysis algorithm for the skin is
probably the one proposed in [56, 57]. The authors model the skin absorbency as a mixture of
melanin, deoxy-haemoglobin and oxy-haemoglobin components. A linear regression associated
with the Beer-Lamber law provides the proportions of these three components at each pixel. More
generally, feature extraction for spectral images has been widely studied. Methods of features
extraction considering a linear combination of spectral bands are PCA ([16]), NAPCA ([18]),
SVD ([4]), or ICA ([9, 22]) that tend to extract features by minimizing the correlation or higher
order statistics. The NMF approach ([39]) searches for features by factorizing the signal matrix
into two non negative matrices. This factorization can be done by minimizing the mean square
error or the Kullback-Leibler divergence for example ([14, 30]). Algorithms such as N-FINDR
([63, 15, 11]), PPI ([7, 42]) or VCA ([38]) analyse the geometry of the data set in the spectral
Nb dimensional space to extract features deﬁned as extreme points in this set. We can also cite
supervised methods like DAFE ([27]), NWFE ([28, 29]) or a maximum likelihood based approach
([52]).
Inria
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In this report, to reduce the computational time induced by the huge volume of multispectral
images, we propose to select the best band with respect to the contrast criterion. We have shown
in [47] that although simple, this approach provides results comparable to more sophisticated
techniques such as ICA.
Change detection In the literature, numerous methods have been proposed to quantify the
changes between two images. They consider the image either globally using pixelwise operations
such as subtraction or division ([33, 50, 54, 32, 31]) or locally with a window that browses the
image ([45, 1, 53, 8, 23, 64]). In each cases, a change map is thresholded to obtain a binary map
of changes.
To take into account spatial information we adapt in this report the SPM approach developed
to analyze fMRI data ([17]). This last step represents our main contribution that leads to a
diﬀerential score quantifying the eﬃciency of a treatment.
2.2 Segmentation
The goal of the segmentation step is to select a region of interest in each image at baseline
(t0) to be followed during the time sequence. In this paragraph, we summarize a work detailed
in [46] and [48]. The segmentation of skin hyperpigmented areas is performed in three steps.
First, the image spectrum dimensionality is reduced in order to remove redundancy and avoid
the Hughes phenomenon using a projection pursuit algorithm ([46]). Second, the shading eﬀect
due to the volumes of the face (nose, eyes) (see Figures 3(a), 3(d) and 3(g)) is compensated to
ensure an accurate segmentation. We ﬁrst remove the background inhomogeneity using a Fourier
high pass ﬁlter and subtract the near infrared spectral band from each of the other bands. The
near infrared has been chosen to remove shading since this band contains few skin pigmentation
information. On this transformed dataset, the segmentation is performed using support vector
machine (SVM). The SVM is trained on a few representative normalized images of the clinical
study. The SVM can then generalize to segment all the images. Examples of training data are
shown in Figures 3(b), 3(e) and 3(h). The variability of the disease between patients makes this
segmentation task diﬃcult. To be sure the pathological area is detected on each image, we created
an interactive software that allows a human operator to manually correct the segmentation if
necessary. We generate two other segmentations by Gaussian mixture analysis associated with
the connected component analysis using two sets of parameters ([48]). We also partition the
SVM segmentation using the connected component analysis. We then get three segmentation.
These maps allow an operator to select the area of interest by clicking the components to be kept.
Figures 3(c), 3(f) and 3(i) show the obtained segmentation on three diﬀerent patients. Figure 4
shows an example of correction of the segmentation using the two additional segmentation.
2.3 Spectral criterion: contrast
To extract a spectral feature of the studied disease, we assume that we have extracted a region
of healthy skin and a region of pathological skin for each series of co-registered multispectral
images. For a given patient, at a given time tk, we thus have four regions: I
pS
tk
and IhStk the
pathological and healthy regions on the cheek treated with the studied treatment, and IpCtk and
IhCtk the pathological and healthy regions on the cheek treated with the comparator treatment.
We consider these four regions to compute the weights of a linear combination M of the spectral
bands:
M(I) =
Nb∑
b=1
mbI(b), (3)
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 3: Images used for the global training. (a,d,g) are color reconstructed images by spectral
integration. The color reconstruction is used only for visualization. (b,e,h) are ﬁltered images by
volume compensation and Fourier high pass ﬁlter at 40%, red rectangles show training patho-
logical areas, and blue rectangles show training healthy areas. (c,f,i) are the surrounding of the
pathological area detected by the proposed method.
where mb is the weight of the b
st spectral band I(b) of the image I and Nb the number of
spectral bands in the initial multispectral image. We look for the combination that gives the
highest contrast between the healthy areas and the pathological areas.
We ﬁrst introduce a normalization step that combines the four regions IpStk , I
hS
tk
, IpCtk , I
hC
tk
.
The ﬁrst normalization combines the healthy and the pathological areas. We can either consider
only the pathological area or compute the diﬀerence between healthy and pathological areas. The
second normalization combines the studied treatment S and the comparator treatment C. We use
the method proposed in clinical protocols that calculates the diﬀerence S−C. Depending on the
use or not of the healthy area, S = µM (I
e,pS
tk
) or S = µM (I
e,hS
tk
)−µM (Ie,pStk ) and C = µM (Ie,pCtk )
or C = µM (I
e,hC
tk
)− µM (Ie,pCtk ), we have two possible normalizations:
Detk = µM (I
e,pS
tk
)− µM (Ie,pCtk ) (4)
and
Detk = (µM (I
e,hS
tk
)− µM (Ie,pStk ))− (µM (Ie,hCtk )− µM (Ie,pCtk )), (5)
where Detk denotes the darkness for the patient e at time tk and µM (I
hS
tk
) (respectively µM (I
e,pS
tk
),
µM (I
e,hC
tk
), µM (I
e,pC
tk
)) is the spatial average of the spectral feature M over the area Ie,hStk
(respectively Ie,pStk , I
e,hC
tk
, Ie,pCtk ).
Inria
Assessing skin lesion evolution from multispectral image sequences 9
Figure 4: Screenshot of the software that allows to do the interactive segmentation, ﬁrst example.
Top left: segmentation obtained with a ﬁrst set of parameters, top right: segmentation obtained
with a second set of parameters, bottom left one band of the original image, bottom right SVM
chosen component. The user can add a region in the top row to the segmentation obtained from
SVM.
We propose an objective function that maximizes both the distance between pathological and
healthy areas, and the deviation between measurement times. This objective function can be
written as f =
∑tn
t=t1
∑Ne
e=1D
e
tk
−Det0 . Using Detk of equation (5) we get:
f =
Nb∑
b=1
mb
{
tn∑
t=t1
Ne∑
e=1
[
µIe,hSt0
(b)− µIe,pSt0 (b) − µIe,hCt0 (b) + µIe,pCt0 (b)
− µIe,hSt (b) + µIe,pSt (b) +µIe,hCt (b)− µIepCt (b)
]}
. (6)
The function f is linear with respect to the parameters mb of M . The optimization is then
trivial. The solution is the spectral band with the highest contrast if we consider only positive
mb. If we consider also negative mb, the solution is given by two bands.
The darkness criterion is then deﬁned by Detk from equation (4) or (5) depending on the
chosen normalization, and using the equation (6) to deﬁne the linear combination M .
2.4 Change detection
In this section, we describe the two selected methods that we use to extract a binary change
map and a multi-level change map. The binary change map aim at measuring the global area of
changes whereas the multi-level change map intends to evaluate the local changes.
2.4.1 Binary change detection: area
Averaging on a local window to quantify the changes according to each pixel neighborhood tends
to a loss in spatial accuracy that is critical. We perform change detection by subtraction to avoid
the noise induced by division:
F etk/0 = M(I
e
tk
)−M(Iet0), (7)
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where M(Ietk) (respectively M(I
e
t0)) is the spectral feature M of I
e
tk
(respectively Iet0) deﬁned in
equation (3). A threshold τ on F etk/0 allows to get the binary change map:
Betk/0(x) =
{
1 if F etk/0(x) > τ and C
e
t0(x) = 1
0 otherwise
(8)
where x denotes the position of any pixel in the image. The choice of τ is crucial. We propose
a method that computes one threshold τ per image series estimated on the histogram of F et1/0 .
First, we assume that the histogram of F etk/0 is monomodal, symmetric and centred in zero in
the case of no changes. This assumption is justiﬁed since F etk/0 is a centred noise in the case
of no changes. Then, we assume that there are no signiﬁcant changes in the negative part (i.e.
the disease does not become worst). Thus, in the case of no disease decreasing, the number of
positive and negative pixels in F etk/0 should statistically be the same.
The threshold τ is calculated such that: card{x : 0 < F etk/0(x) < τ} = card{x : F etk/0(x) ≤ 0}.
A drawback of the thresholding methods for change detection is their sensitivity to noise. To
decrease the noise, we ﬁlter the change map Betk/0 with opening and closing from mathematical
morphology operators ([55]) using a disk of two pixels as a structural element.
To calculate an area criterion, we propose to compute the spatial changes between tk and t0.
Let us denote Cet0 a segmentation mask at t0 for the patient e obtained by the proposed method.
Then, the area criterion is deﬁned as follows:
Aetk/0 =
card{x : Betk/0(x) = 1 ∧ Cet0(x) = 1}
card{x : Cet0(x) = 1}
. (9)
2.4.2 multi-level change detection: homogeneity
To measure the homogeneity we propose to use a multi-level change detection approach. We
consider the statistical framework based on a contextual hypothesis testing similarly to the
Statistical Parametric Mapping (SPM) ([17, 44]) approach in functional MRI. We model the
change map as a realization of a Gaussian random ﬁeld under the null hypothesis. Then a multi-
scale analysis partition this map into regions and a probability is assigned to each region. These
probabilities measure the likelihood for the regions under the null hypothesis to be a realization of
the random ﬁeld. For our application, we apply this methodology on each change map F etk/0 . To
model F etk/0 as a Gaussian random ﬁeld, we need to normalize it. Then we apply the multi-scale
analysis to get regions and calculate probabilities.
Map normalization The SPM methodology, makes the hypothesis that data follow a highly
correlated standard Gaussian distribution. To satisfy this assumption, we smooth the image F etk/0
with a Gaussian convolution ﬁlter to increase its spatial correlation. Second, as the interest area
of F etk/0 comes from a unique class, its histogram can be modelled as monomodal in the hypothesis
of no changes. We use a histogram speciﬁcation to transform it into a Gaussian distribution.
We center and reduce the speciﬁed histogram to get a standard Gaussian distribution. In the
following we will denote FNetk/0 the normalized change map.
Change map thresholding On the normalized map FNetk/0 we apply the Gaussian ﬁeld theory
([2]). An interesting characteristic of a Gaussian ﬁeld F of size S is the DT (Diﬀerential Topology)
characteristic. We ﬁrst deﬁne the excursion set Au for each threshold u as follows:
Au = {s ∈ S, F (s) ≥ u}. (10)
Inria
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For each connected component Cu(j) of Au, the DT characteristic is given by:
χ(Cu(j)) = (−1)(d−1)
d−1∑
k=0
(−1)kχk(Cu(j)) (11)
where u is a given threshold, d the dimension of the ﬁeld and χk(Au) the number of points
s ∈ Cu(j) satisfying the conditions:
 F (s) = u
 F (i)(s) = 0,∀i ∈ [1, d− 1]
 F (d)(s) > 0
 the (d−1)×(d−1) matrix of second order partial derivatives of F(s) has exactly k negative
eigenvalues.
In the above expression, F (i) denotes the ith partial derivative of F with respect to variable s.
In the 2D case (i.e. d = 2), for a given threshold u the expectation of the DT characteristic of a
centred and reduced Gaussian ﬁeld can be written as follows ([2]):
Eχ(Au) = S(2pi)
3
2 |Λ| 12σ−3ue− u
2
2σ2 (12)
with S the surface of the ﬁeld, Λ the 2 × 2 correlation matrix of the ﬁeld derivatives, and
σ2 = E(F 2).
In order to estimate the likelihood of a connected component of FNetk/0 above the threshold u
under the Gaussian ﬁeld assumption, we compare its characteristic with the DT characteristic.
Two parameters can be used to compute this likelihood: the maximum intensity and the spatial
extent of the considered neighbourhood above u.
Let x0 denotes the maximum intensity of R
x0
u a region above the threshold u. The likelihood
of this region under the Gaussian ﬁeld assumption is ([44]):
P (Rx0u ∈ F ) =
Eχ(Ax0 )
Eχ(Au)
=
x0
u
e
u2−x20
2 . (13)
Let S0 denotes the spatial extent of R
S0
u a region above the threshold u. The expectation for
this region under the Gaussian ﬁeld assumption is ([44]):
E(RS0u ∈ F ) =
E(Nu)
Eχ(Au)
, (14)
where E(Nu) is the expectation to have Nu pixels above the threshold u in a Gaussian random
ﬁeld F . As F follows a standard normal distribution,
E(Nu) = S
∫ ∞
u
(2pi)
1
2 e−
x2
2 = SΦ(−u) (15)
then,
E(RS0u ∈ F ) =
Φ(−u)
(2pi)
3
2 |Λ| 12ue−u22
. (16)
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Algorithm 1 Multi-scale analysis
Require: I0, Ik, Mp0
1: F etk/0 = Ik − I0
2: Smooth and normalize F etk/0 to get F
Ne
tk/0
(see section 2.4.2)
3: Choose a family U = u1, ..., unu
4: for i = 1 to nu do
5: Compute the connected components above ui
6: for each connected component do
7: Calculate x0 and S0
8: Calculate P (Rx0,S0u ∈ F ) with eq. 18
9: end for
10: end for
11: Merge the obtained connected clusters obtained with the family U to get SMetk
Thus, the number of pixels in a region above the threshold u has an exponential distribution
with the parameter λu = 1/E(RS0u ∈ F ). We can then write the probability of a region RS0u to
appear in a realization of the Gaussian ﬁeld by:
P (RS0u ∈ F ) = e−λuS0 = e
(2pi)
3
2 |Λ|
1
2 S0ue
−u2
2
Φ(−u) (17)
Finally, the probability for a spatial region above u with maximum intensity x0 and spatial
extend S0, to be in F is:
P (Rx0,S0u ∈ F ) = min(P (Rx0u ∈ F ), P (RS0u ∈ F )). (18)
Thereby, to detect changes between t0 and tk we deﬁne a family of n thresholds U =
{u(1), ..., u(n)}. For each u(i), we consider the connected components Ru(i) of the map F etk/0
thresholded at u(i). Then we assign a probability P (Rx0,S0u(i) ∈ F ) to each region Rx0,S0u(i) (see
Figure 5). This process gives a statistical change map between t0 and tk for each threshold of U .
A ﬁnal change map denoted SMetk between t0 and tk is obtained by merging the change maps
obtained for each thresholds of U . This merging consists of stacking the changes maps sorted
in increasing value of u. This stacking method allows to get all the obtained regions in a single
map showing level set of the pathology changes. The algorithm 1 summarizes the procedure for
obtaining SMtk between I0 and Ik for a given patient.
normalization The statistical approach proposed in Section 2.4.2 makes the hypothesis that
changes are rare events. In our images, a large part of the pathological area can change. That
breaks this assumption (see Figure 6 d to f). This result is an underdetection of the changes.
Homogeneity variations cannot be quantiﬁed in these maps. We propose then to introduce the
following normalization:
FNdetk/0 = F
Ne
tk/0
+
1
Nr
tk∑
r=t0
(
µCt0 (F
Ne
tr/0
)− µCt0 (FNet1/0)
)
(19)
where Nr is the number of time measurements between t0 and tk. µCt0 (F
Ne
tr/0
) (respectively
µCt0 (F
Ne
t1/0
)) denotes the average of the pixel intensities in the ROI of FNetr/0 (respectively F
Ne
t1/0
)
delimited by Ct0 . As the normalized data using Equation (19) do not respect the rare event
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Figure 5: Muli-scale analysis illustration. Green: map thresholded at u(1), red: map thresholded
at u(2) > u(1), and gray: regions below u(1) and u(2). A probability is assigned to each region
above the thresholds u1 and u2.
hypothesis, the computed statistics are biased. Nevertheless, we do not use the absolute values
of these statistics but their spatial repartition. Figure 6 g to i shows SMetk cartographies obtained
with the normalization given by Equation (19). The pathology evolution is now visible during
the time sequence.
Homogeneity criterion To quantify the homogeneity evolution we integrate the multi-scale
change maps into a scalar value. To do so, we deﬁne a function fes (p) that represents the spatial
repartition of the changes by:
fes (p) =
card{x : SMetk(x) ≤ p}
card{SMetk}
. (20)
fes (p) is an increasing function from [0, 1] to [0, 1]. To be able to represent the homogeneity with
respect to the surface, we prefer to work with fpetk (s) that is the inverse function of f
e
s (p). A
linear interpolation is used to calculate fpetk (s) with a regular sampling along (si). f
pe
tk
(s) is also
an increasing function from [0, 1] to [0, 1]. In the following, we use fpetk (s) for both calculating a
graphical representation of the homogeneity criterion (see section 5), and a scalar Hetk describing
the homogeneity of the patient e at time tk.
To integrate fpetk (s) in a scalar H
e
tk
∈ [0, 1], we compute:
Hetk = 2
∫ 1
0
|fpetk (s)− s|ds '
∑
i
2|fpetk (si)− si|(si+1 − si). (21)
Hetk represents the area between the function f
pe
tk
(s) and the identity function Id(s) = s. Id cor-
responds to the most heterogeneous repartition that can be expected. Then, more homogeneous
changes yield higher values Hetk .
3 Experimental settings
In this section, we introduce the database constituted of two clinical studies that is used for
validating the proposed method and we expose the protocol that we use to evaluate it.
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 6: Changes map of the diﬀerential score for a patient whose pathology decreases during
the treatment period. a-c) equalized diﬀerence image on the spectral feature map between each
time t1, t2 and t3 and t0, d-f) homogeneity maps SM
e
tk
for the three time t1, t2 and t3 without
using the normalization of Equation (19) w.r.t g-i) homogeneity maps SMetk for the three time
t1, t2 et t3 using the normalization of Equation (19).
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3.1 Database
The database we use it made of 2 clinical studies. The ﬁrst one involves three active treatments
that are denoted St, Ad1 and Ad2. Each treatment is tested on a population of 16 patients.
For each patient, one cheek receives one of the treatments St, Ad1 or Ad2 and the second cheek
receives a comparator. The study lasts 3 months and two multispectral images are taken for
each patient (one per cheek) every month. Thus, we have 3 ∗ 16 ∗ 2 = 96 series of four images
corresponding to times t0 = baseline, t1 = after one month, t2 = after two months and t3 =
after three months. The total amount of images of the ﬁrst clinical study is therefore equal to
384. The images are of a size of 1200*960 pixels, and contain 18 spectral bands with wavelengths
varying from 405 nm to 970 nm. For this ﬁrst clinical study, the dermatologists conclusions state
that St has no eﬃcacy whereas Ad1 and Ad2 have eﬃcacy. Furthermore, Ad2 has a stronger eﬀect
than Ad1.
The second clinical study compares two treatments denoted T and A. Each treatment is tested
on a population of 22 patients. Thus, the clinical study involve 44 patients. For each patient,
one cheek receives one of the treatments T or A and the second cheek receives a comparator.
The protocol of this study is the same as for the ﬁrst clinical study. Then, this study involve 352
multispectral images.
3.2 Evaluation protocol
The proposed diﬀerential score composed of three criteria (darkness, area and homogeneity)
appears as a numeric equivalent of the MASI criterion deﬁned by dermatologists. We evaluate
the three components individually. In order to evaluate the accuracy of the severity changes
of this new score, we used it on the clinical studies cited above. For each of these two clinical
studies, dermatologists scored the MASI for each patient at each visit. From the obtained table
of scores, we are able to compute statistical hypothesis tests to evaluate if a treatment had an
eﬀect or not, due to the MASI criterion. After the hypothesis testing, if the p-value of the test
is below 0.05, we consider that the score signiﬁcantly changed between two measurements and
then conclude that the treatment had an eﬀect. In the experiment section, we run the proposed
diﬀerential score on the whole dataset of the clinical studies. With the obtained table of scores,
we can perform the same statistical testing as with the dermatologists scores. If the results of
the statistical tests using the diﬀerential score and the dermatologists diagnosis match, then we
conclude that the proposed diﬀerential score is accurate. As they are parameters to calibrate
in order to obtain the diﬀerential score, we propose to use the two clinical studies as follows:
the ﬁrst clinical study is used to tune the parameters. This means that, we experimentally test
diﬀerent sets of parameters to ﬁnd which one gives conclusions similar to the dermatologists
scoring. Then we run the diﬀerential score on the second clinical study with the same set of
parameters, to validate the proposed method. If the same set of parameters provides the same
conclusions as the dermatologists on the second clinical study, we conclude that the proposed
diﬀerential score accurately quantify the Melasma evolution.
4 Results
4.1 Darkness
In order to compare the features extraction methods detailed in section 2.3 we calculate the
spectral feature for each treatment St, Ad1 and Ad2 of the ﬁrst clinical study individually. Then
we compute the features in all the images of the study on the four segmented regions IpStk , I
hS
tk
,
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Figure 7: Spectral features obtained by the studied methods.
IpCtk , I
hC
tk
. this results in a darkness measurement Detk for each patient. We ﬁnally apply a
Wilcoxon hypothesis test for each treatment between t0 and tk to get a quantiﬁcation of the
treatment eﬃcacy. Table 1 shows the p-values obtained by the Wilcoxon test with the proposed
method, with the ICA and with the luminance that we use as a reference feature. Equation (5) is
used for normalization. As one can see, all the features agree with the clinical conclusions. The
diﬀerence is in how fast we can detect an eﬃcacy of the treatment. The method based on the
objective function optimization gives a faster detection compared to the ICA-based method and
the luminance. To understand this diﬀerence, we plot the features obtained by all the methods
in Figure 7. As the luminance coeﬃcient is not linear, we use its linear approximation Y . We
observe that the feature obtained by f selects a speciﬁc band at 590 nm for the treatments
St, and Ad2 and the band 645 nm for the treatment Ad1. ICA selects spectral bands mainly
around 600 nm, but sets signiﬁcant coeﬃcients to wavelengths between 400 and 600 nm. The
Y feature selects bands in the 500-600 nm wavelengths. Due to the Stamatas et al. model
for pigmentation ([57]) we should focus on the wavelengths between 600 and 700 nm. Thus, a
possible interpretation to explain why the ICA based method and the Y features detect later
the treatments eﬃcacy than the feature estimated by f , is there high coeﬃcients in the spectral
ranges out of 600-700 nm. Table 2 shows the results obtained with the Wilcoxon test on the
same studies with the normalization given by Equation (4). The results are comparable to the
ones obtained with the normalization given by Equation (5). This means that the calibration of
the camera is robust and that the normalization using the healthy area is not mandatory. As
this normalization can introduce noise due to the variation of the healthy area, we prefer to use
the normalization given by Equation (4). To validate the spectral features calculated on the ﬁrst
clinical study, we apply them on the second study described in section 3.1. The p-values of the
Wilcoxon tests on the second study are shown in Table 3. For f we choose the feature b590−b405.
Obtained results are totally coherent with the clinical analysis. We can then conclude that the
proposed darkness criterion using the f feature is accurate and consistent with the dermatologist
diagnosis.
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Table 1: P-values obtained by the Wilcoxon test on the ﬁrst clinical study with the normalization
of Equation (5) for the darkness criterion.
Feature Treatment t1 − t0 t2 − t0 t3 − t0
L
St 7.959 10
−1 5.014 10−1 7.173 10−1
Ad1 3.793 10
−1 1.128 10−2 8.793 10−2
Ad2 9.798 10
−2 3.204 10−3 5.312 10−4
f
St 1.476 10
−1 1.089 10−1 7.563 10−1
Ad1 5.571 10
−2 3.400 10−2 4.373 10−2
Ad2 8.360 10
−3 3.204 10−3 9.350 10−4
ICA
St 5.349 10
−1 8.767 10−1 9.176 10−1
Ad1 4.080 10
−1 2.987 10−2 9.798 10−2
Ad2 7.873 10
−2 5.233 10−3 9.350 10−4
Table 2: P-values obtained by the Wilcoxon test on the ﬁrst clinical study with the normalization
of Equation (4) for the darkness criterion.
Feature Treatment t1 − t0 t2 − t0 t3 − t0
L
St 7.959 10
−1 6.791 10−1 6.416 10−1
Ad1 1.306 10
−2 2.289 10−2 9.798 10−2
Ad2 1.788 10
−1 7.169 10−3 1.918 10−3
f
St 7.173 10
−1 5.349 10−1 5.014 10−1
Ad2 2.289 10
−2 1.737 10−2 3.400 10−2
Ad3 1.997 10
−2 1.609 10−3 9.725 10−3
ICA
St 6.416 10
−1 5.694 10−1 5.014 10−1
Ad1 1.997 10
−2 3.400 10−2 8.793 10−2
Ad2 1.476 10
−1 7.169 10−3 1.123 10−3
Table 3: P-values obtained by the Wilcoxon test on the second clinical study for the darkness
criterion.
Test Treatment t1 − t0 t2 − t0 t3 − t0
L
A 8.455 10−1 7.210 10−1 1.270 10−1
T 9.741 10−1 9.397 10−3 1.637 10−3
f
A 1.116 10−1 5.373 10−1 9.777 10−2
T 4.750 10−1 3.859 10−3 9.337 10−3
ICA
A 7.210 10−1 5.589 10−1 1.627 10−1
T 8.966 10−1 6.389 10−3 3.478 10−3
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(a) (b) (c)
(d) (e) (f)
Figure 8: Changes map for a patient whose pathology decreases during the treatment period.
a-c) equalized diﬀerence image on the spectral feature map between each time t1, t2 and t3 and
t0, d-f) change detection map used to measure the area for each times t1, t2 and t3. Changed
areas are drawn in black.
Table 4: p-values of the Wilcoxon tests on the second clinical study for the area criterion.
Criterion Treatment t1 − t0 t2 − t0 t3 − t0
Area
A 2.840 10−1 3.986 10−1 1.045 10−1
T 4.552 10−1 3.478 10−3 2.438 10−4
4.2 Area
The area criterion does not have parameters to calibrate. Thus, we can test this criterion directly
on the second clinical study. Figure 8 d-f) shows obtained results for an image time series. For
this patient, dermatologists clinically measure a decrease of the pathology. As one can see, the
area measured by the algorithm shows a signiﬁcant evolution at time t1 and then a gradual
evolution of the pathological area. To validate this area measurement, we calculate change areas
Aetk/0 for all the patients of the second clinical studies. As for the darkness measurement, we
compute the Wilcoxon test for each treatment between t0 and tk in the area measurements.
Results are shown in Table 4. Results show that the treatment T has an eﬀect whereas the
treatment A does not has any. This is in agreement with the dermatologist diagnosis.
4.3 Homogeneity
To validate the proposed homogeneity criterion, we ﬁrst calibrate the parameters of the model
using images series from patients of the ﬁrst clinical study. These patients were selected to be
identiﬁed to have a decreasing pathology by the dermatologists. We then apply the homogeneity
calculation on the second study. The homogeneity measure makes sense only when some changes
appear in the image between t0 and tk. A margin is then ﬁxed at 10% of the pathological
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Figure 9: Time sequences of the homogeneity measurements for the patients of the group for
which an evolution has been measured by the area and darkness criteria.
area changes below which we do not consider the criterion Hetk . To qualitatively evaluate the
homogeneity criterion, we plot its evolution for the population of patients whose pathology
evolves. Due to the darkness and the area criteria, the considered patients are those who received
the treatment T in the second study. Figure 9 shows time plots of the homogeneity measurement
for each patient of the group receiving the treatment T . If the treatment has an eﬀect, we expect
to see the homogeneity measurement growing. In this population of 22 patients, the H criterion
is not interpretable for 7 patients. Indeed, for ﬁve patients less than 10% of the pathological
area changes at time t2 = 8 or t3 = 12 and for two patients there were less than 10% of
the pathological area that changes in all the time sequence. For the other ﬁfteen patients we
globally observe the expected growth of the homogeneity with time. For most patients (in blue)
main changes occurred in the second measurement time t1 = 4, and for 4 patients (in red), main
changes occurred in time t2 = 8. These results show that the homogeneity criterion gives relevant
interpretation of disease regression during treatment. This criterion is by deﬁnition interpretable
only on patients whose pathology has evolved.
5 Discussions and Conclusions
5.1 Discussions
In this report we proposed a diﬀerential score that allows computing the evolution of the
Melasma severity along a clinical study. This diﬀerential score is composed of three indepen-
dent scores that are the darkness, the area and the homogeneity. The MASI described in [41]
and [26] calculates a linear combination of darkness, area and homogeneity measurements (see
Equations (1) and (2)). For the proposed diﬀerential score, such a combination does not have
any meaning. Indeed, the three criteria have diﬀerent dynamics, and combining them can bias
the ﬁnal measurement. That is why we prefer to use the three measurements independently.
Besides, in practice the homogeneity of the MASI is usually not used by dermatologists and
removed from the global score.
Furthermore, the proposed diﬀerential score summarizes the variation of pathology between
two images with 3 numbers that represent diﬀerent aspects of the treatment eﬃcacy. To make
the diﬀerential score easily readable for an individual patient we use a graphical representation
as follows:
RR n° 8745
20 Prigent & al.
(a) (b) (c)
Figure 10: Darkness graphical representation. a) for a patient whose pathology became darker,
b) for a patient with stationary darkness, c) for a patient whose pathology decreases.
(a) (b) (c)
Figure 11: Area graphical representation. a) for a patient with stationary pathological area, b)
for a patient whose pathological area decreases by 26%, c) for a patient whose pathological area
decreases by 86%.
Darkness representation The proposed darkness criterion is a diﬀerential measure between
two monochrome images. Its theoretical magnitude is then [−255, 255] for 8 bit images. In
practice, the magnitude observed in our data set is in the interval [−12, 12]. To visualize the
changes of D, we compute DG the darkness value used for the graphical representation by
shrinking the representation area using a curve with a shape given by:
DG =
D√
1 +D2
. (22)
The darkness bar contains a chip with a color from red (-12) to blue (+12). This chip position
on the bar depends on the DG value from -12 to 12. Figure 10 shows three examples of darkness
representation bars.
Area representation The area criterion we proposed has values in the interval [0, 1]. The
graphical representation we have chosen is then a percentage bar. Figure 11 shows examples of
graphical representation of the area criterion.
Homogeneity representation For the graphical representation of the homogeneity criterion,
we propose to use fpetk (s). In fact this information is richer than H
e
tk
. The graphical bar of
homogeneity is then a plot of fpetk (s) with a gradient color. Values of f
pe
tk
(s) close to zero are shown
in blue and values of fpetk (s) close to one are given in red. Intermediate values are represented with
the jet colormap. If the gradient is all red, that means there is no homogeneity variation. The
slower the gradient changes from blue to red, the more heterogeneous the variation is. Figure 12
shows examples of the homogeneity bar.
Diﬀerential score representation Finally, a diﬀerential score representation can be the com-
bination of the three bars of darkness, area and homogeneity. An example for a patient whose
(a) (b) (c)
Figure 12: Homogeneity graphical representation. a) for a patient without evolution of the
pathology, b) for a patient with heterogeneous variation of the pathology, c) for a patient with
homogeneous variation of the pathology.
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(a) (b) (c)
(d) (e) (f)
Figure 13: Graphical representation of the diﬀerential score for a patient whose pathology de-
creases during the treatment period. a-c) equalized diﬀerence image on the spectral feature map:
t1 − t0, t2 − t0 and t3 − t0, d-f) graphical representation of the diﬀerential score for the three
times t1, t2 and t3.
pathology decreases is shown in Figure 13 and an example for a patient whose pathology does
not decrease is shown in Figure 14. As one can see, with this graphical representation, we can
both quantify and qualify the patient pathology evolution.
5.2 Conclusion
In this report, we proposed a strategy to calculate the severity of skin hyperpigmentation using
multispectral images. The proposed criterion called diﬀerential score has been developed to be
a computer score related to the clinical MASI criterion. The proposed diﬀerential score has been
tested on a full clinical study and has given relevant results with respect to the clinical analysis.
Advantages of our method are that it can estimate the spectral feature of diseases through the
training phase using the reference data set, and that no prior knowledge is required in the spatial
analysis. As such, our method can be adapted to analyze other pathologies such as vitiligo, scars
or rosacea.
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(a) (b) (c)
(d) (e) (f)
Figure 14: Graphical representation of the diﬀerential score for a patient whose pathology did
not decrease during the treatment period. a-c) equalized diﬀerence image on the spectral feature
map: t1 − t0, t2 − t0 and t3 − t0, d-f) graphical representation of the diﬀerential score for the
three times t1, t2 et t3.
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